Sugandh FN, Chandio M, Raveena FN, Kumar L, Karishma FN, Khuwaja S, Memon UA, Bai K, Kashif M, Varrassi G, Khatri M (2023) Advances in the management of diabetes mellitus: a focus on personalized medicine. Cureus 15(8):e43697
PubMed PubMed Central Google Scholar
Yedjou CG, Grigsby J, Mbemi A, Nelson D, Mildort B, Latinwo L, Tchounwou PB (2023) The management of diabetes mellitus using medicinal plants and vitamins. Int J Mol Sci 24(10):9085
Article CAS PubMed PubMed Central Google Scholar
Varghese S, Kumar SG (2019) Association between genetic variants of NOS3, TGF-β and susceptibility of diabetic nephropathy: a meta-analysis. Meta Gene 1(21):100573
Lerma E, White WB, Bakris G (2023) Effectiveness of nonsteroidal mineralocorticoid receptor antagonists in patients with diabetic kidney disease. Postgrad Med 135(3):224–233
Article CAS PubMed Google Scholar
Thomas MC, Cooper ME, Zimmet P (2016) Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol 12(2):73–81
Article CAS PubMed Google Scholar
Hoogeveen EK (2022) The epidemiology of diabetic kidney disease. Kidney Dial 2(3):433–442
Liu H, Feng J, Tang L (2022) Early renal structural changes and potential biomarkers in diabetic nephropathy. Front Physiol 8(13):1020443
Arnalich F, Hernanz A, Lopez-Maderuelo D, Pena JM, Camacho J, Madero R, Vazquez JJ, Montiel C (2000) Enhanced acute-phase response and oxidative stress in older adults with type II diabetes. Horm Metab Res 32(10):407–412
Article CAS PubMed Google Scholar
Sultan S, Alharbi M, Alrayes N, Makki N, Faruqui H, Basuni L, Alhozali A, Abdulnoor R, Borai A, Almalki A, Alzahrani A (2023) Association of a single nucleotide polymorphism in SOD2 with susceptibility for the development of diabetic nephropathy in patients with type 2 diabetes: a Saudi population study. Endocrinol Diabet Metab 12:e449
Houldsworth A, Hodgkinson A, Shaw S, Millward A, Demaine AG (2015) Polymorphic differences in the SOD-2 gene may affect the pathogenesis of nephropathy in patients with diabetes and diabetic complications. Gene 569(1):41–45
Article CAS PubMed Google Scholar
Klen J, Goričar K, Janež A, Dolžan V (2015) Common polymorphisms in antioxidant genes are associated with diabetic nephropathy in Type 2 diabetes patients. Pers Med 12(3):187–198
Hodgkinson AD, Bartlett T, Oates PJ, Millward BA, Demaine AG (2003) The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy. Diabetes 52(3):846–851
Article CAS PubMed Google Scholar
Nomiyama T, Tanaka Y, Piao L, Nagasaka K, Sakai K, Ogihara T, Nakajima K, Watada H, Kawamori R (2003) The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. J Hum Genet 48(3):138–141
Article CAS PubMed Google Scholar
Lee SJ, Choi MG, Kim DS, Kim TW (2006) Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients. Metabolism 55(1):1–7
Article CAS PubMed Google Scholar
Elsaid A, Samireid O, Said SB, Zahran RF (2021) Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients. J Genet Eng Biotechnol 19:1–1
Liu L, Zheng T, Wang N, Wang F, Li M, Jiang J, Zhao R, Li L, Zhao W, Zhu Q, Jia W (2009) The manganese superoxide dismutase Val16Ala polymorphism is associated with decreased risk of diabetic nephropathy in Chinese patients with type 2 diabetes. Mol Cell Biochem 322:87–91
Article CAS PubMed Google Scholar
Luo Y, Luo J, Peng H (2019) Associations between genetic polymorphisms in the VEGFA, ACE, and SOD2 genes and susceptibility to diabetic nephropathy in the Han Chinese. Genet Test Mol Biomark 23(9):644–651
Yahya MJ, Ismail PB, Nordin NB, Akim AB, Binti Md Yusuf WS, Adam NL, Zulkifli NF (2019) CNDP1, NOS3, and MnSOD polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients in Malaysia. J Nutr Metab 2019:8736215
Article PubMed PubMed Central Google Scholar
Mollsten A, Marklund SL, Wessman M, Svensson M, Forsblom C, Parkkonen M, Brismar K, Groop PH, Dahlquist G (2007) A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy. Diabetes 56(1):265–269
Jerotic D, Matic M, Suvakov S, Vucicevic K, Damjanovic T, Savic-Radojevic A, Pljesa-Ercegovac M, Coric V, Stefanovic A, Ivanisevic J, Jelic-Ivanovic Z (2019) Association of Nrf2, SOD2 and GPX1 polymorphisms with biomarkers of oxidative distress and survival in end-stage renal disease patients. Toxins 11(7):431
Article CAS PubMed PubMed Central Google Scholar
Albeladi FI, Mostafa MM, Zayed MA, Atta H (2022) Association of polymorphisms in antioxidant enzyme-encoding genes with diabetic nephropathy in a group of saudi arabian patients with type ii diabetes mellitus. Int J General Med 1:5919–5928
Panduru NM, Ion DA, Mota M, Cimponeriu D, Stavarachi M, Pisoschi C, Radu S, Anghel M, Mota E (2011) Glutathione peroxidase 1 (GPX-1) Pro200Leu polymorphism and diabetic nephropathy in type 1 diabetes: a preliminary study. Rom Biotech Lett 16(5).
Mohamed AA, Al-Saadi AH, Zaidan HK (2021) GPx1-rs1050450 gene polymorphism association with end stage renal disease in Type2 diabetic patients of Babylon Province/Iraq. Indian J Foren Med Toxicol 15(2):2017–2021
Jassim M, Dehghan G, Khosroshahi HT, Haghi M (2023) Genetic polymorphism of SOD2 and GPx1 modify oxidative stress biomarkers in an Iranian population with chronic kidney disease. J Popul Ther Clin Pharmacol 30(1):593–603
Hong EP, Park JW (2012) Sample size and statistical power calculation in genetic association studies. Genom Inform 10:117–122
Khoshdel-Rad N, Zahmatkesh E, Shpichka A, Timashev P, Vosough M (2021) Outbreak of chronic renal failure: will this be a delayed heritage of COVID-19? J Nephrol 34:3–5
留言 (0)